Edgar G. Engleman, MD, Director and Founder
Dr. Engleman is Professor of Medicine and Pathology of the Stanford University School of Medicine and Director of the Stanford Blood Center. He received his Bachelor's degree from Harvard University and his M.D. from Columbia University School of Medicine. He completed three postgraduate training programs and now runs a research laboratory at Stanford focused on the discovery and development of novel immunotherapeutic approaches to cancer and autoimmune diseases. He co-founded Cetus Immune, Genelabs, National Medical Audit, Dendreon, and CellGate. Dr. Engleman is also a Member of BioAsia Investments, a venture investment company investing in life sciences companies, and serves on the board of directors of several private biopharmaceutical companies.